Latest News
- Palestine Full UN Entry Backed By Kuwait
- Expatriate Clicks On Link, Loses All Savings
- Kuwait Weekend Weather: Hot Weather And Scattered Rain
- Former MP Tabtabaie Goes To Trial On May 20
- Missing Algerian Man For 25 Years Found And Held Captive By Neig...
- Citizen Detained For Alleged Involvement With A Banned Group
- Kuwait And Ethiopia To Sign MoU For Domestic Workers Recruitment
- Service Bureau Announces Training Plans For Employees And Gradua...
- Filipino Worker Remittances Decline In Kuwait
- Health Ministry Reaffirms Commitment To Modernizing Healthcare S...
- Interior Minister: The Law Will Be Applied To All With All Serio...
- Municipality Considers Postponing Wedding Tent Removal
India’s Bharat Biotech Reveals Covid Vaccine Shows 81 Percent Efficacy
India’s COVID-19 vaccine produced by Bharat Biotech has shown an interim vaccine efficacy of 81 percent in late-stage clinical trials, the company based in the southern city of Hyderabad said.
The interim analysis was based on 43 recorded cases of COVID-19 in the trial of 25,800 participants, conducted in partnership with the Indian Council of Medical Research (ICMR) – India’s premier medical research body.
Thirty-six of the 43 cases were recorded in participants who received a placebo, compared with seven cases in people who were given the Bharat Biotech vaccine, pointing to an efficacy rate of 80.6 percent, the company said on Wednesday.
India had approved the vaccine, branded COVAXIN, in January without late-stage efficacy data, raising questions about its effectiveness.
But the move was hailed by Prime Minister Narendra Modi as a success in India’s push towards self-reliance.
The vaccination drive in the world’s second-most populous nation, currently under way, includes COVAXIN and a vaccine developed by Oxford University and AstraZeneca, named Covishield.
World’s largest vaccine manufacturer
India is the country second-worst hit by COVID-19 with more than 11 million cases. Nearly 160,000 people have died due to the disease.
Serum Institute of India (SII), the world’s largest vaccine manufacturer, has been producing the Covishield vaccine in partnership with Oxford University and the British company.
Earlier this week, Indian Prime Minister Modi was inoculated with the first dose of COVAXIN. Many of his ministers followed suit, opting for the Indian vaccine.
India has vaccinated more than 10.5 million healthcare and front-line workers since beginning its immunisation campaign on January 16.
But only 1.2 million, or about 11 percent, of them, have taken the locally developed COVAXIN, while the remaining 9.4 million have used the Oxford-AstraZeneca vaccine, according to the government’s Co-Win online platform used to track the vaccination drive.
SOURCE TIMESKUWAIT
Trending News
-
Ministry Systems Hacked, Electricity Bills Altered
11 May 2024
-
Kuwait Unveils Monumental Solar Energy Project For...
06 May 2024
-
Expatriates Caught On Video Stealing Electricity W...
11 May 2024
-
Team To Inspect New Airport's Solar Panel Installa...
12 May 2024
-
Gulf Electrical Interconnection Project Will Boost...
04 May 2024
-
Issuing Work Permits Based On Academic Certificate...
07 May 2024
-
Kuwait Banks Seek Clarity From Central Bank On Cit...
04 May 2024
-
Kuwait Cracks Down On Bachelors
02 May 2024
-
Kuwait Organizes 30 Events To Protect Children Fro...
04 May 2024
-
Eid Al-Adha Holiday In Kuwait: Potential 9-Day Bre...
15 May 2024
Comments Post Comment